Cargando…

Choosing the right combination therapy in severe community-acquired pneumonia

Recent studies have suggested that combination antibiotic therapy is preferable to monotherapy for severe community-acquired pneumonia (CAP). In this issue Mortensen and colleagues present retrospective data suggesting that combination therapy with a cephalosporin and a fluoroquinolone is inferior t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waterer, Grant W, Rello, Jordi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550800/ https://www.ncbi.nlm.nih.gov/pubmed/16469123 http://dx.doi.org/10.1186/cc3976

Ejemplares similares

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get
por: Salluh, Jorge IF, et al.
Publicado: (2011)

Advances in community-acquired pneumonia
por: Jones, Barbara, et al.
Publicado: (2020)

Demographics, guidelines, and clinical experience in severe community-acquired pneumonia
por: Rello, Jordi
Publicado: (2008)

Diagnosing Viral and Atypical Pathogens in the Setting of Community-Acquired Pneumonia
por: Waterer, Grant W.
Publicado: (2017)

ICU admission and severity assessment in community-acquired pneumonia
por: Chalmers, James D
Publicado: (2009)

Hot topics and current controversies in community-acquired pneumonia
por: Severiche-Bueno, Diego, et al.
Publicado: (2019)

Community-acquired bacterial pneumonia in adults: An update
por: Eshwara, Vandana Kalwaje, et al.
Publicado: (2020)

Adjunctive and Supportive Measures for Community-Acquired Pneumonia
por: Waterer, G. W., et al.
Publicado: (2010)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Can Electronic Decision Support Tools Really Reduce Mortality from Community-acquired Pneumonia?
por: Waterer, Grant, et al.
Publicado: (2022)

Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials
por: Bouras, Marwan, et al.
Publicado: (2023)

Burden of Community-Acquired Pneumonia and Unmet Clinical Needs
por: Ferreira-Coimbra, João, et al.
Publicado: (2020)

Causes of non-adherence to therapeutic guidelines in severe community-acquired pneumonia
por: Gattarello, Simone, et al.
Publicado: (2015)

The simple and the simpler in pneumonia diagnosis
por: Lisboa, Thiago, et al.
Publicado: (2007)

Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All
por: Waterer, Grant W., et al.
Publicado: (2020)

The MDCK variety pack: choosing the right strain
por: Dukes, Joseph D, et al.
Publicado: (2011)

Improvement of antibiotic therapy and ICU survival in severe non-pneumococcal community-acquired pneumonia: a matched case–control study
por: Gattarello, Simone, et al.
Publicado: (2015)

Macrolides and community-acquired pneumonia: is quorum sensing the key?
por: Wise, Matt P, et al.
Publicado: (2010)

Corticosteroids for community-acquired pneumonia: time to act!
por: Annane, Djillali, et al.
Publicado: (2008)

Management of Pseudomonas aeruginosa pneumonia: one size does not fit all
por: Rello, Jordi, et al.
Publicado: (2014)

Reply to Huttner et al.: 2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use
por: Metlay, Joshua P., et al.
Publicado: (2020)

COVID-19: First Do No Harm
por: Waterer, Grant W., et al.
Publicado: (2020)

Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia
por: Montull, Beatriz, et al.
Publicado: (2016)

Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis
por: Vidaur, Loreto, et al.
Publicado: (2019)

Community-acquired pneumonia in the United Kingdom: a call to action
por: Chalmers, James, et al.
Publicado: (2017)

Ability of the LACE index to predict 30-day hospital readmissions in patients with community-acquired pneumonia
por: Dobler, Claudia C., et al.
Publicado: (2020)

Lack of Association of the Caspase-12 Long Allele with Community-Acquired Pneumonia in People of African Descent
por: Chen, Jiwang, et al.
Publicado: (2014)

COVID-19, steroids and other immunomodulators: The jigsaw is not complete
por: Rello, Jordi, et al.
Publicado: (2020)

Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical Outcomes
por: Upchurch, Cameron P., et al.
Publicado: (2018)

Predicting treatment failure in severe sepsis and septic shock: looking for the Holy Grail
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2013)

Genetic epidemiology of acute lung injury: choosing the right candidate genes is the first step
por: Christie, Jason D
Publicado: (2004)

Lower Respiratory Tract Virus Findings in Mechanically Ventilated Patients With Severe Community-Acquired Pneumonia
por: Karhu, J., et al.
Publicado: (2014)

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Di Pasquale, Marta Francesca, et al.
Publicado: (2019)

The Impact of Viral Infections in Children with Community-Acquired Pneumonia
por: Mameli, Chiara, et al.
Publicado: (2013)

Non-invasive diagnosis of variceal bleeding: choose the right target population and identify the right culprit
por: Calès, Paul, et al.
Publicado: (2020)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l2lpojo269nudnnptpcht005sb